Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

364 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Chronic graft-versus-host disease could ameliorate the impact of adverse somatic mutations in patients with myelodysplastic syndromes and hematopoietic stem cell transplantation.
Caballero JC, Sánchez Barba M, Hernández Sánchez JM, Such E, Janusz K, Sanz G, Cabrero M, Chillón C, Cervera J, Hurtado AM, Jerez A, Calderón Cabrera C, Valcárcel D, Lumbreras E, Abáigar M, López Cadenas F, Hernández Rivas JM, Del Cañizo MC, Díez Campelo M. Caballero JC, et al. Among authors: cervera j. Ann Hematol. 2019 Sep;98(9):2151-2162. doi: 10.1007/s00277-019-03751-6. Epub 2019 Jul 16. Ann Hematol. 2019. PMID: 31312927
Prolonged molecular remission after PML/RAR alpha-positive autologous peripheral blood stem cell transplantation in acute promyelocytic leukemia: is relevant pretransplant minimal residual disease in the graft?
Sanz MA, de la Rubia J, Bonanad S, Barragán E, Sempere A, Martín G, Martínez JA, Jiménez C, Cervera J, Bolufer P, Sanz GF. Sanz MA, et al. Among authors: cervera j. Leukemia. 1998 Jun;12(6):992-5. doi: 10.1038/sj.leu.2401024. Leukemia. 1998. PMID: 9639431
Autologous blood stem cell transplantation for acute myeloblastic leukemia in first complete remission. Intensification therapy before transplantation does not prolong disease-free survival.
de la Rubia J, Sanz GF, Martín G, Martínez J, Cervera J, Solves P, Jiménez C, Arnao M, Vicente A, Jarque I, Sempere A, Sanz MA. de la Rubia J, et al. Among authors: cervera j. Haematologica. 1999 Feb;84(2):125-32. Haematologica. 1999. PMID: 10091410 Clinical Trial.
Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes. Grupo Cooperativo Español de Citogenética Hematológica.
Solé F, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Luño E, Prieto F, Granada I, Hernández JM, Cigudosa JC, Diez JL, Bureo E, Marqués ML, Arranz E, Ríos R, Martínez Climent JA, Vallespí T, Florensa L, Woessner S. Solé F, et al. Among authors: cervera j. Br J Haematol. 2000 Feb;108(2):346-56. doi: 10.1046/j.1365-2141.2000.01868.x. Br J Haematol. 2000. PMID: 10691865 Free article.
Unrelated donor cord blood transplantation in adults with chronic myelogenous leukemia: results in nine patients from a single institution.
Sanz GF, Saavedra S, Jiménez C, Senent L, Cervera J, Planelles D, Bolufer P, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, de la Rubia J, Barragán E, Solves P, Soler MA, Sanz MA. Sanz GF, et al. Among authors: cervera j. Bone Marrow Transplant. 2001 Apr;27(7):693-701. doi: 10.1038/sj.bmt.1702878. Bone Marrow Transplant. 2001. PMID: 11360108 Clinical Trial.
Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies.
Sanz GF, Saavedra S, Planelles D, Senent L, Cervera J, Barragán E, Jiménez C, Larrea L, Martín G, Martínez J, Jarque I, Moscardó F, Plumé G, Andreu R, Regadera AI, García I, Mollá S, Solves P, de La Rubia J, Bolufer P, Benlloch L, Soler MA, Marty ML, Sanz MA. Sanz GF, et al. Among authors: cervera j. Blood. 2001 Oct 15;98(8):2332-8. doi: 10.1182/blood.v98.8.2332. Blood. 2001. PMID: 11588027 Free article. Clinical Trial.
364 results